NICE to recommend rimegepant as first acute migraine treatment

NICE has approved rimegepant as the first treatment for acute migraine, in draft guidance published today. Around 13,000 could benefit from rimegepant (Vydura, Pfizer), said NICE after signing off its use in adults who have tried at least two triptans but they did not work well enough. It can also be used for those in... Read moreThe post NICE to recommend rimegepant as first acute migraine treatment appeared first on Nursing in Practice.
Source: Nursing in Practice - Category: Nursing Authors: Tags: Clinical Latest news Women's health Source Type: news